Organic Ion Transporters and Statin Drug Interactions Kenneth Kellick Statin Drugs (Barbara Wiggins, Section Editor) 25 November 2017 Article: 65
Community Interventions to Increase Stroke Preparedness and Acute Stroke Treatment Rates Kathleen M. KellyKathryn T. HoltLesli E. Skolarus Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 16 November 2017 Article: 64
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target Ronodeep MitraGerard Leland O’NeilEno Essien Ebong Vascular Biology (J. Hamilton, Section Editor) Open access 10 November 2017 Article: 63
ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen Natalia A. RochaCara EastPeter A. McCullough Nonstatin Drugs (E. deGoma, Section Editor) 09 November 2017 Article: 62
Implementing Evidence-Based Practices for Acute Stroke Care in Low- and Middle-Income Countries Rasha KhatibAssef M. JawaadaMark D. Huffman Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 08 November 2017 Article: 61
Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids Megan F. BurkeFrances M. BurkeDaniel E. Soffer Nonstatin Drugs (E. deGoma, Section Editor) 07 November 2017 Article: 60
Early Rehabilitation After Stroke: a Narrative Review Elisheva R. ColemanRohitha MoudgalWuwei Feng Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor) 07 November 2017 Article: 59
Cardiovascular Risk Factors After Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): a New Effective Therapeutic Approach? Antonio TorresMiguel A. RubioAndrés Sánchez-Pernaute Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 07 November 2017 Article: 58
Atherosclerosis, Periodontal Disease, and Treatment with Resolvins James A. HamiltonHatice HasturkThomas Van Dyke Vascular Biology (J. Hamilton, Section Editor) 06 November 2017 Article: 57
Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications Rahul R. GoliMayur M. ContractorJay Giri Nonstatin Drugs (E. deGoma, Section Editor) 04 November 2017 Article: 56
Novel Approaches for HDL-Directed Therapies Jacques GenestHong Y. Choi Nonstatin Drugs (E. deGoma, Section Editor) 04 November 2017 Article: 55
The Emergence of “Simpler” Surgical Options to Treat Obesity and Metabolic Syndrome Ricardo Cohen Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 02 November 2017 Article: 54
Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis G. E. SandaA. D. BelurNehal N. Mehta Vascular Biology (J. Hamilton, Section Editor) 30 October 2017 Article: 53
Improving Regional Stroke Systems of Care Melissa S. EngAnand V. PatelJeffrey M. Katz Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 24 October 2017 Article: 52
Is Mini-Gastric Bypass a Rational Approach for Type-2 Diabetes? Reem Abou GhazalehMatthieu BruzziJean-Marc Chevallier Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 24 October 2017 Article: 51
Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology Joseph R. GeraghtyFernando D. Testai Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor) 23 October 2017 Article: 50
PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies Petra El KhourySandy ElbitarMarianne Abifadel Genetics and Genomics (Ali Marian, Section Editor) 17 October 2017 Article: 49
The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis Michael GarshickJames A. Underberg Statin Drugs (B. Wiggins, Section Editor) 17 October 2017 Article: 48